Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mani S Mahadevan

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|October 9, 2010
Genetics. Exposing a DUX taleMani S Mahadevan
Cell Stem Cell|April 9, 2011
Myotonic muscular dystrophy, RNA toxicity, and the brain: trouble making the connection?Mani S Mahadevan
Current Opinion in Neurology|August 16, 2012
Myotonic dystrophy: is a narrow focus obscuring the rest of the field?Mani S Mahadevan
Developmental Biology|January 21, 2004
Myogenic defects in myotonic dystrophyJeffrey D Amack, Mani S Mahadevan
Clinical Chemistry|December 23, 2004
Genotype-phenotype correlations: assessing the influence of sequence variants on the clinical phenotypeLawrence M Silverman, Mani S Mahadevan
Clinical Chemistry|July 26, 2005
Factor V null mutation affecting the Roche LightCycler factor V Leiden assayMani S Mahadevan, Paul V Benson
Muscle & Nerve|May 25, 2011
Therapeutics development in myotonic dystrophy type 1Erin Pennock Foff, Mani S Mahadevan
International Journal of Molecular Sciences|March 13, 2024
Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle RegenerationRamesh S Yadava, Mahua Mandal, Mani S Mahadevan
International Journal of Molecular Sciences|November 13, 2021
Cardiac Pathology in Myotonic Dystrophy Type 1Mani S Mahadevan, Ramesh S Yadava, Mahua Mandal
Current Protocols|February 23, 2023
Detecting RNA-Protein Interactions With EGFP-Cy3 FRET by Acceptor PhotobleachingShagufta Rehman Alam, Mani S Mahadevan, Ammasi Periasamy
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|October 9, 2010
Genetics. Exposing a DUX taleMani S Mahadevan
Cell Stem Cell|April 9, 2011
Myotonic muscular dystrophy, RNA toxicity, and the brain: trouble making the connection?Mani S Mahadevan
Current Opinion in Neurology|August 16, 2012
Myotonic dystrophy: is a narrow focus obscuring the rest of the field?Mani S Mahadevan
Developmental Biology|January 21, 2004
Myogenic defects in myotonic dystrophyJeffrey D Amack, Mani S Mahadevan
Clinical Chemistry|December 23, 2004
Genotype-phenotype correlations: assessing the influence of sequence variants on the clinical phenotypeLawrence M Silverman, Mani S Mahadevan
Clinical Chemistry|July 26, 2005
Factor V null mutation affecting the Roche LightCycler factor V Leiden assayMani S Mahadevan, Paul V Benson
Muscle & Nerve|May 25, 2011
Therapeutics development in myotonic dystrophy type 1Erin Pennock Foff, Mani S Mahadevan
International Journal of Molecular Sciences|March 13, 2024
Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle RegenerationRamesh S Yadava, Mahua Mandal, Mani S Mahadevan
International Journal of Molecular Sciences|November 13, 2021
Cardiac Pathology in Myotonic Dystrophy Type 1Mani S Mahadevan, Ramesh S Yadava, Mahua Mandal
Current Protocols|February 23, 2023
Detecting RNA-Protein Interactions With EGFP-Cy3 FRET by Acceptor PhotobleachingShagufta Rehman Alam, Mani S Mahadevan, Ammasi Periasamy
Pageof 4